This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (21)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Allergy  • Neurology  • Review  • Neurocutaneous Diseases  • Pain  • Hypersensitivity  • Alert me on articles by topic

Interaction of Itch and Pain

Akihiko Ikoma, MD; Roman Rukwied, PhD; Sonja Ständer, MD; Martin Steinhoff, MD, PhD; Yoshiki Miyachi, MD; Martin Schmelz, MD, PhD

Arch Dermatol. 2003;139:1475-1478.

The discovery of an itch-specific neuronal pathway, which is distinct from the pain-processing pathway, has clarified the neuronal basis for the itch sensation. Albeit being distinct, there are complex interactions between pain and itch. The inhibition of itch by pain is well known and can explain the antipruritic effect of scratching. However, the opposite effect also exists and has major clinical implications: inhibition of pain processing (eg, by spinal opioids) can generate itch. Conversely, blockade of spinal opioid receptors can be used as an antipruritic therapy. Moreover, the spinal processing of pain and itch can be modulated, resulting in a hypersensitivity or hyposensitivity to pain or itch: similar to chronic painful conditions, ongoing activity of pruriceptors can induce a spinal hypersensitivity for itch in patients with chronic pruritus. Therapeutic antipruritic approaches therefore should target both local inflammation and spinal sensitization of itch processing.

From the Department of Dermatology, Kyoto University, Kyoto, Japan (Drs Ikoma and Miyachi); Department of Anesthesiology–Mannheim, University of Heidelberg, Mannheim, Germany (Drs Rukwied and Schmelz); and Department of Dermatology, University of Muenster, Muenster, Germany (Drs Ständer and Steinhoff). The authors have no relevant financial interest in this article.

RELATED ARTICLES

Neuronal Sensitization for Histamine-Induced Itch in Lesional Skin of Patients With Atopic Dermatitis
Akihiko Ikoma, Roman Rukwied, Sonja Ständer, Martin Steinhoff, Yoshiki Miyachi, and Martin Schmelz
Arch Dermatol. 2003;139(11):1455-1458.
ABSTRACT | FULL TEXT  

Neurophysiology of Pruritus: Cutaneous Elicitation of Itch
Sonja Ständer, Martin Steinhoff, Martin Schmelz, Elke Weisshaar, Dieter Metze, and Thomas Luger
Arch Dermatol. 2003;139(11):1463-1470.
ABSTRACT | FULL TEXT  

Modern Aspects of Cutaneous Neurogenic Inflammation
Martin Steinhoff, Sonja Ständer, Stephan Seeliger, John C. Ansel, Martin Schmelz, and Thomas Luger
Arch Dermatol. 2003;139(11):1479-1488.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intravenous nalbuphine 50 {micro}g{middle dot}kg-1 is ineffective for opioid-induced pruritus in pediatrics: [La nalbuphine intraveineuse a 50 {micro}g{middle dot}kg-1 est inefficace contre le prurit induit par les opioides chez des enfants].
Nakatsuka et al.
Canadian J. Anesthesia 2006;53:1103-1110.
ABSTRACT | FULL TEXT  

Prophylactic Intravenous Ondansetron and Dolasetron in Intrathecal Morphine-Induced Pruritus: A Randomized, Double-Blinded, Placebo-Controlled Study
Iatrou et al.
Anesth. Analg. 2005;101:1516-1520.
ABSTRACT | FULL TEXT  

Neurophysiology of Pruritus: Cutaneous Elicitation of Itch
Stander et al.
Arch Dermatol 2003;139:1463-1470.
ABSTRACT | FULL TEXT